Clinical Trials · NCT06922318
The COSMYC Trial (COmbined Suppression of MYC)
- Phase
- Phase 2
- Recruitment status
- Recruiting
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- Enrollment
- 50
- Start date
- Aug 2025
- Locations
- 1 site, United States
- Primary endpoint
- Clinical/radiographic progression free survival (PFS) with BATZEN